We constructed a hybrid Moloney murine leukaemia virus (MoMLV) bearing both a chimeric CD4 and the wild-type MoMLV envelope protein (Env) on its surface. The chimeric molecule, consisting of a surface domain of CD4 and the C-terminal two-thirds of MLV Env, was expressed on the cell surface. When expressed in MoMLV-infected cells, the CD4-Env chimera was incorporated into the virion as efficiently as the wild-type MoMLV Env. The hybrid MoMLV could infect human HeLa cells (although not with high efficiency) only if the cells were expressing human immunodeficiency virus type 1 genome. This method of ligand incorporation into a virion may lead to a development of a cell-specific retroviral vector for targeting gene therapy.
AdachiA.,
GendelmanH. E.,
KoenigS.,
FolksT.,
WilleyR.,
RabsonA.,
MartinM. A.1986; Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of Virology 59:284–291
DorfmanT.,
MammanoF.,
HaseltineW. A.,
GottlingerH. G.1994; Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology 68:1689–1696
EinfeldD.,
HunterE.1988; Oligomeric structure of a prototype retrovirus glycoprotein. Proceedings of the National Academy of Sciences, USA 85:8688–8692
Etienne-JulanM.,
RouxP.,
CarilloS.,
JeanteurP.,
PiechaczykM.1992; The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. Journal of General Virology 73:3251–3255
JonesD. S.,
NemotoF.,
KuchinoY.,
MasudaM.,
YoshikuraH.,
NishimuraS.1989; The effect of specific mutations at and around the gag-pol gene junction of Moloney murine leukemia virus. Nucleic Acids Research 17:5933–5945
MaddonP. J.,
LittmanD. R.,
GodfreyM.,
MaddonD. E.,
ChessL.,
AxelR.1985; The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42:93–104
MatanoT.,
OdawaraT.,
OhshimaM.,
YoshikuraH.,
IwamotoA.1993; Irani-Dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus. Journal of Virology 67:2026–2033
MatanoT.,
OdawaraT.,
OhshimaM.,
IwamotoA.,
YoshikuraH.1994; Interaction between the dominant negative mutant and the wild-type envelope proteins of Friend murine leukemia virus. Journal of Virology 68:6079–6082
PatuleiaM. C.,
FriendC.1967; Tissue culture studies on murine virus-induced leukemia cells: isolation of single cells in agar-liquid medium. Cancer Research 27:726–730
RouxP.,
JeanteurP.,
PiechaczykM.1989; A versatile and potentially general approach to the targeting of specific cell types by recombinant retroviruses. Proceedings of the National Academy of Sciences, USA 86:9079–9083
SaikiR. K.,
Buga WanT. L.,
HornG. T.,
MullisK. B.,
ErlichH. A.1986; Analysis of enzymatically amplified β-globin and HLA-DQα dna with allele-specific oligonucleotide probes. Nature 293:543–548
SuomalainenM.,
GaroffH.1994; Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. Journal of Virology 68:4879–4889
Valsesia-WittmannS.,
DryndaA.,
DeleageG.,
AumailleyM.,
HeardJ.-M.,
DanosO.,
VerdierG.,
CossetF.-L.1994; Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. Journal of Virology 68:4609–4619
WeissR. A.1993; Cellular receptors and viral glycoproteins involved in retrovirus entry. In The Retroviridae vol 2 pp 1–108 Edited by
LevyJ. A.
New York: Plenum Press;
YuX.,
YuanX.,
MatsudaZ.,
LeeT.-H.,
EssexM.1992; The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. Journal of Virology 66:4966–4971